Relmada Therapeutics (RLMD) Other Operating Expenses (2012 - 2022)
Relmada Therapeutics' (RLMD) quarterly Other Operating Expenses came in at $6.4 million in Q2 2022, up 878407.05% on a QoQ basis from $723.0 in Q1 2013.
Relmada Therapeutics (RLMD) Other Operating Expenses (2012 - 2022) Analysis & Trends
Relmada Therapeutics (RLMD) has 3 years of Other Operating Expenses data on file, last reported at $6.4 million in Q2 2022.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $6.4 million in Q2 2022; TTM through Mar 2023 was $6.4 million, a N/A change from a year earlier, with the FY2022 full-year figure at $6.4 million, changed N/A from the prior year.
- Other Operating Expenses for Q2 2022 stood at $6.4 million, up from $723.0 in the prior quarter.
- Over the last five years, Other Operating Expenses for RLMD reached as high as $6.4 million in Q2 2022 and fell as low as $6.4 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 6.35 Mn |
| Feb 28, 2013 | 723.00 |
| Nov 30, 2012 | 309.00 |
| Aug 31, 2012 | 1,048.00 |